To create a better and healthier days for woman around the world, Organon hosted a thought leadership panel discussion, "Accelerating advancements in the health of women across the region" forum at EXPO 2020
Held in partnership with the United States Chamber of Commerce, the USA Pavilion, Jhpiego and Friends of Cancer Patients, Organon convened the forum of global experts and industry thought-leaders to better understand the existing gaps in women's healthcare and explore potential solutions. Attended by many guests, among them His Excellency Dr Amin Al Amiri and Megan Gregonis, the United States Consul General in Dubai the forum marked the launch of Organon in the MENAT region.
With a portfolio spanning Women's Health, Biosimilars and Established Brands, Organon is globally focusing exclusively on women's health. Keen to shift the focus of women's healthcare beyond female reproduction to unaddressed needs, the healthcare company, which serves 140 markets with 60 medicines and solutions, is now operating across the UAE, Oman, Kuwait, Qatar, KSA, Egypt, Lebanon, Jordan, Turkey and Ukraine. In line with the UN Sustainable Development Goal for gender equality and female empowerment, Organon's mission is to improve and innovate across the women's healthcare space.
Commenting on the launch, Ramy Koussa, associate vice-president, Organon MENAT, said, "Our goal is to advance women's healthcare across MENAT by addressing their unmet needs, helping to build a healthier and a brighter future for all women, families and communities. Leveraging our existing global footprint and expertise and working closely with local authorities and industry stakeholders, we are keen to shift the women's health paradigm beyond reproductive health to encompass the entire life cycle. This forum is an important first for us at Organon MENAT in providing a platform to listen to women and becoming a trusted women's healthcare partner in the region.
Among the topics discussed by the women's healthcare experts were existing gaps in data that act as a barrier to improving women's health, how to monitor progress toward the UN Sustainable Goal of gender equality, investments in healthcare and accelerating change through economic empowerment. Attending panelists included: Dr Susanne Fiedler, chief commercial officer of Organon; Susanne Mikhail, regional director of United Nations Entity for Gender Equality and the Empowerment of Women for the Arab States; Bathylle Missika, head of the Networks, Partnerships and Gender Division at OECD Development Centre; Myra Betron, director of Gender at Jhpeigo; and Dina El- Shenoufy, chief investment officer at Flat6lab.
